JUSTIN WELBORN: Open Payments
NPI 1245653252 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 23 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $199 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| SCILEX PHARMACEUTICALS INC. | 7 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Valinor Pharma, LLC | 4 | $65 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Virtus Pharmaceuticals LLC | 2 | $42 |
| PFIZER INC. | 2 | $32 |
| Globus Medical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: ZTLido, RELISTOR, MOVANTIK, Belbuca, LEVORPHANOL TARTRATE, NURTEC ODT, Senza, UBRELVY.
Industry payments across LA — which companies pay providers there.
